Flavor Bans Proposed in Maine and San Francisco

Jan.12.2023
Flavor Bans Proposed in Maine and San Francisco
Maine considers statewide ban on flavored tobacco as part of a growing trend in the US. Study on San Francisco flavor ban reveals mixed results.

Following the approval of tobacco product bans in four cities in Maine, state senator Jill Duson from Portland is expected to introduce a bill proposing a statewide ban on flavored tobacco products.


If passed, Maine will join a number of other US states, including Massachusetts, New Jersey, and New York, in implementing flavored tobacco product restrictions. Dan Cashman, spokesperson for advocacy group Flavors Hook Kids Maine, stated that State Senator Jill Duson from Portland is expected to soon propose a bill containing the ban.


This is crucial," said Kashman. "Maine cannot wait any longer. Every day, the children of Maine are being drawn in by these marketing ploys and tobacco products targeted towards young people. These are dangerous and addictive products.


At the same time, a study examining the ban on flavored e-cigarettes in San Francisco has reported shocking findings. Titled "The Impact of San Francisco's Comprehensive Tobacco Flavor Ban on Youth", the research aims to determine the effects of the ban on tobacco use behavior. A sample of 247 San Francisco residents were surveyed on their e-cigarette and tobacco use before and after the flavor ban.


The study found that although the ban did lead to a decrease in sales of electronic cigarettes and cigars, unfortunately it also resulted in a surge in smoking rates. Additionally, researchers found that the measure was not properly enforced, with 65% of participants reporting that they were able to obtain flavored products by various means.


According to these research findings, a comprehensive ban on local flavors cannot significantly reduce the supply or use of flavored tobacco products among residents. However, local bans can still significantly reduce overall use of e-cigarettes and cigar consumption, but may increase the use of traditional cigarettes. This was concluded by the study.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

U.S. Health Groups Seek to Overturn FDA Enforcement Discretion for Pending PMTAs as Altria's Helix, NJOY and AVM Move to Intervene
U.S. Health Groups Seek to Overturn FDA Enforcement Discretion for Pending PMTAs as Altria's Helix, NJOY and AVM Move to Intervene
American Vapor Manufacturers (AVM) and Altria subsidiaries Helix Innovations and NJOY filed separate motions on October 7, 2026, seeking to intervene on the FDA's side in a lawsuit challenging its enforcement guidance for certain e-cigarette and nicotine pouch products with pending premarket tobacco product applications (PMTAs). Seven public health and tobacco-control organizations, including the Campaign for Tobacco-Free Kids, sued the agency in July to overturn the policy. AVM argues that vacating the guidance could disrupt orders, inventory, retail distribution and investments in regulatory submissions.
Regulations
Oct.09
PMI Launches Fourth IQOS Convenience-Store Discount of 2026 for Black Friday in Japan, Cutting ILUMA i ONE to About $19 After Ploom AURA Fell to About $9
PMI Launches Fourth IQOS Convenience-Store Discount of 2026 for Black Friday in Japan, Cutting ILUMA i ONE to About $19 After Ploom AURA Fell to About $9
Philip Morris Japan launched its fourth confirmed nationwide convenience-store discount campaign for IQOS ILUMA i devices in 2026 on October 26, cutting three models by as much as ¥2,000, or about $12.70. The campaign began one day after JT ended a promotion that reduced Ploom AURA to ¥1,480, or about $9.40. JT says Ploom's share of Japan's heated-products category rose from 10.9% in January 2024 to 18.3% in June 2026, a gain of 7.4 percentage points, while PMI says IQOS still held about 68% category share in the third quarter. At the same time, Japan's two-stage heated-tobacco tax adjustment has pushed stick prices higher, leaving device discounts as an increasingly important tool for lowering the upfront cost of customer acquisition.
Market
Oct.28
Imperial Brands' NGP Revenue Rises 11.4% in FY2026 but Business Still Posts £63 Million Loss; Zone Reaches 114,000 US Stores as Smokeless Reporting Takes Shape
Imperial Brands' NGP Revenue Rises 11.4% in FY2026 but Business Still Posts £63 Million Loss; Zone Reaches 114,000 US Stores as Smokeless Reporting Takes Shape
Imperial Brands reported an 11.4% increase in next-generation product (NGP) net revenue to £419 million in fiscal 2026, while its adjusted NGP operating loss narrowed to £63 million. European NGP revenue rose 16.8%, while the Americas recorded a 17.1% decline. Global modern oral nicotine volumes increased 27.8%, with US nicotine pouch brand Zone expanding to approximately 114,000 stores. The company also acquired Black Buffalo in the US and Helwit in Sweden, broadening its oral nicotine portfolio. From FY2027, Imperial Brands will adopt a new Smokeless reporting category combining NGP with traditional oral tobacco. On the new basis, FY2026 Smokeless net revenue was £554 million, with adjusted operating profit of £14 million.
company
Nov.18
South Korea's Tobacco Plan Excludes 6-Methyl Nicotine as Customs Tightens Import Controls and Analog Liquid Imports Fall 83%
South Korea's Tobacco Plan Excludes 6-Methyl Nicotine as Customs Tightens Import Controls and Analog Liquid Imports Fall 83%
South Korea's government unveiled its first Tobacco Harm Management Basic Plan for 2027–2031 on October 29, 2026, proposing broader testing of vaping and heated tobacco products while excluding nicotine analogs such as 6-methyl nicotine. Synthetic nicotine came under tobacco regulation on April 24, and a June investigation found 6-methyl nicotine in 12 liquid inhalation products marketed as nicotine-free. Customs data released in September showed that imports of nicotine analog solutions fell 83.3%, from 12 metric tons in January–April to 2 metric tons in May–August. By September 20, imports had reached approximately 15 metric tons for the year, with 99.99% originating from China. Customs authorities have tightened pre-clearance testing and supply-chain documentation requirements, while the MFDS expects to complete its assessment of nicotine analog hazards by the end of 2026.
Regulations
Nov.04
Iowa Vape Directory Exposes Retail Divide: Specialty Vape Retailer Route 69 Vapor Says Over 98% of Its Inventory Is Unlisted, While Convenience Chains Casey’s, Maverik and Tobacco Giant Altria Previously Backed the Law
Iowa Vape Directory Exposes Retail Divide: Specialty Vape Retailer Route 69 Vapor Says Over 98% of Its Inventory Is Unlisted, While Convenience Chains Casey’s, Maverik and Tobacco Giant Altria Previously Backed the Law
Iowa published its first vapor products directory on November 16, 2026, restricting retail sales to products covered by 361 listed entries. In interviews published on November 18, independent vape retailers described inventory restrictions, revenue exposure and store closure plans. Route 69 Vapor said more than 98% of its inventory was excluded from the directory, while Central Iowa Vapors said approximately 91% of its existing product assortment was unlisted. A mixed tobacco retailer reported nearly $15,000 in vape inventory that suppliers would not accept for return. Iowa legislative records show that convenience store and fuel retail chains Casey’s and Maverik, along with tobacco company Altria, supported the legislation establishing the directory in 2024. The new rules also affect licensed distributors, wholesalers and manufacturers, bringing supply-chain arrangements into the dispute over retail access.
Regulations
Nov.19
Why Does JPMorgan Favor BAT Over Philip Morris Despite Forecasting Slower Growth of 3.9% Versus 6.2%?
Why Does JPMorgan Favor BAT Over Philip Morris Despite Forecasting Slower Growth of 3.9% Versus 6.2%?
JPMorgan resumed equity research coverage of British American Tobacco (BAT), Philip Morris International (PMI) and Imperial Brands in November 2026, assigning BAT an Overweight rating and the other two companies Neutral ratings. The bank forecasts like-for-like sales growth of 3.9% for BAT and 6.2% for PMI in 2027, but estimates the two companies will trade at approximately 11 times and 21 times 2027 earnings, respectively. JPMorgan cited BAT's improving position in US nicotine pouches and vaping products as a driver of its investment outlook. BAT reported a 220% constant-currency increase in US modern oral nicotine revenue in the first half of 2026, while PMI's ZYN US shipments returned to growth in the third quarter. Imperial expects NGPs to represent 4% to 5% of sales and has expanded its oral portfolio through acquisitions.
Capital Markets
Nov.12